Only tumor grade, P53 positivity, and negative hormone receptors had an association with HER2 positivity in the study of Prati et al. The difference between these and our results may be explained by the larger size of tumors in our patients which is due to the absence of a breast cancer screening program in our country. The gene discussed is TP53; the disease is breast carcinoma.